Although we see dramatic inhibition of the proliferation on breast cancer cells following G7-18NATE peptide treatment, we have not been able to detect changes in phosphorylation of ERK or AKT, two known molecules that have a role in cell survival downstream of ErbB2. This evidence concerns the gene ERBB2 and breast cancer.